Barclays Sees Upside For Cigna Even With No Deal As Icahn Opposes Merger
August 07, 2018 at 13:32 PM EDT
If the deal is approved, the analyst sees Cigna shares falling to $180 in the near-term.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.